HUA MEDICINE
(HKEX: 2552)
Hua Medicine Ltd. provides drug discovery and development services. It offers drugs for diabetes and Central Nervous System disorders. Its products include Dorzagliatin HMS552, Dorzagliatin+Metformin, Dorzagliatin+DPPIV, Dorzagliatin+SGLT-2, Dorzagliatin+Insulin, Dorzagliatin+GLP-1 and mGLUR5 NAM. The company was founded by Chen Li on November 10, 2009 and is headquartered in Shanghai, China.
1.530 -
+0.070
(+4.79%)
Range
1.460 - 1.530
(4.79%)
Open
1.460
Previous Close
1.460
Bid Price
1.500
Bid Volume
('000)
2.5
Ask Price
1.530
Ask Volume
('000)
21.5
Volume
('000)
732.5
Value
1,090,625
Remark
-
Delayed prices. Updated at 20 Dec 2024 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
